Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness

Area of Science:

• Immunology
• Allergy and Asthma Research
• T cell Biology

Background:

• Allergic asthma is a complex respiratory syndrome.
• Airway inflammation and hyper-responsiveness are key features of asthma.

Purpose of the Study:

• To investigate the role of CD8(+) T cell subsets in allergen-induced asthma.
• To determine if effector (T(EFF)) or central memory (T(CM)) CD8(+) T cells are responsible for asthma pathogenesis.

Main Methods:

• Utilized a mouse model of allergen-induced airway hyper-responsiveness (AHR).
• Compared responses in CD8-deficient mice versus wild-type mice.
• Performed adoptive transfer of antigen-primed T(EFF) and T(CM) cells into CD8-deficient mice.
• Analyzed bronchoalveolar lavage fluid for eosinophilic inflammation and IL-13 levels.
• Assessed T cell accumulation in the lungs and intracellular cytokine production.

Main Results:

• CD8-deficient mice exhibited significantly lower AHR, eosinophilic inflammation, and IL-13 levels compared to wild-type mice.
• Adoptive transfer of T(EFF) cells, but not T(CM) cells, restored AHR, inflammation, and IL-13 levels in CD8-deficient mice.
• Transferred T(EFF) cells accumulated in the lungs and were identified as a source of IL-13.

Conclusions:

• Effector CD8(+) T cells play a critical role in the development of allergic asthma.
• The capacity of T(EFF) cells to produce IL-13 and migrate to the lungs contributes to AHR and airway inflammation.
• Targeting effector CD8(+) T cells may offer a therapeutic strategy for allergic asthma.